Abyrx Revenue and Competitors
Estimated Revenue & Valuation
- Abyrx's estimated annual revenue is currently $5M per year.
- Abyrx's estimated revenue per employee is $251,000
Employee Data
- Abyrx has 20 Employees.
- Abyrx grew their employee count by 11% last year.
Abyrx's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Senior Director Commercial Operations | Reveal Email/Phone |
2 | Product Development Engineer | Reveal Email/Phone |
Abyrx Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $5M | 40 | -18% | $10M | N/A |
#2 | $24.8M | 99 | 29% | N/A | N/A |
#3 | $84.1M | 0 | N/A | $1.2M | N/A |
#4 | $35.6M | 142 | 30% | N/A | N/A |
#5 | $57.5M | 229 | 6% | N/A | N/A |
#6 | $52.7M | 168 | 25% | $129.6M | N/A |
#7 | $21.1M | 84 | -3% | N/A | N/A |
#8 | $61.2M | 244 | -13% | N/A | N/A |
#9 | $60.6M | 193 | 20% | $115.5M | N/A |
#10 | $56.2M | 179 | -3% | $122.9M | N/A |
What Is Abyrx?
An exciting new biosurgical products company. Guided by a seasoned management team comprised of physicians, Ph.D.'s and business leaders, Abyrx is positioned to provide safe and effective surgical solutions from which patients will benefit, surgeons will find superior to existing products and administrators will find cost effective.
keywords:N/A
N/A
Total Funding
20
Number of Employees
$5M
Revenue (est)
11%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Abyrx News
ABYRX, GPC Medical, Medtronic, Ethicon, Futura Surgicare, B. Braun Melsungen, Surgical Specialties, Medline, Baxter, WNDM Medical,...
ABYRX; Ethicon; B. Braun Melsungen; Medtronic; Baxter; Medline; Futura Surgicare; GPC Medical; WNDM Medical; Surgical Specialties; Bentley...
Bone Wax Market Size, Share and Trends 2022-2028, Forecast Key Players | ABYRX, GPC Medical, Medtronic, Ethicon, Futura Surgicare, B. Braun...
Other Companies in
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $2.9M | 20 | 0% | N/A |
#2 | $4.5M | 20 | -23% | N/A |
#3 | $2.9M | 20 | -20% | N/A |
#4 | $3.5M | 20 | 5% | N/A |
#5 | $2M | 20 | N/A | N/A |